Morningside

To add a bio or update investment portfolio, please click update information.

Investment Portfolio

Cyted Health raises £32.5m Series B led by British Business Bank, EQT and Advent Life Sciences to expand gastrointestinal diagnostics

1 Sept 2025

Cyted Health raises £32.5m Series B led by British Business Bank, EQT and Advent Life Sciences to expand gastrointestinal diagnostics

Cyted Health develops minimally invasive diagnostic tests for gastrointestinal disease, combining cell collection devices with molecular biomarkers to detect conditions earlier.

Morningside

- Health
1(12 months)
morningside.com
Update Information

More venture news

Olix
3 Aug 2026
OLIX unlocks £240m Series B led by Fundomo to develop specialised AI inference chips for each stage of token production
Series BDeep Tech
Mironid
5 Aug 2026
Mironid raises a £34m Series B including £8.4m from Scottish National Investment Bank to advance small molecule treatments for kidney diseases
Series BLife Sciences
Greyparrot
29 Jul 2026
Greyparrot raises £20m Series B from angels for AI camera systems that read waste on recycling belts
Series BClimate

Morningside

Investment Portfolio

Cyted Health raises £32.5m Series B led by British Business Bank, EQT and Advent Life Sciences to expand gastrointestinal diagnostics

More venture news

OLIX unlocks £240m Series B led by Fundomo to develop specialised AI inference chips for each stage of token production

Mironid raises a £34m Series B including £8.4m from Scottish National Investment Bank to advance small molecule treatments for kidney diseases

Greyparrot raises £20m Series B from angels for AI camera systems that read waste on recycling belts